Adenocarcinoma: Difference between revisions
Line 279: | Line 279: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Endometrial Cancer | | style="background: #DCDCDC; padding: 5px; text-align: center;" | Endometrial Cancer | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Vulvar Cancer | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 304: | Line 317: | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | Gold Standard | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | Gold Standard | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | Additional Findings | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | Additional Findings | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Prostate Cancer | | style="background: #DCDCDC; padding: 5px; text-align: center;" | Prostate Cancer |
Revision as of 17:04, 7 March 2019
Template:DiseaseDisorder infobox
WikiDoc Resources for Adenocarcinoma |
Articles |
---|
Most recent articles on Adenocarcinoma Most cited articles on Adenocarcinoma |
Media |
Powerpoint slides on Adenocarcinoma |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Adenocarcinoma at Clinical Trials.gov Trial results on Adenocarcinoma Clinical Trials on Adenocarcinoma at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Adenocarcinoma NICE Guidance on Adenocarcinoma
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Adenocarcinoma Discussion groups on Adenocarcinoma Patient Handouts on Adenocarcinoma Directions to Hospitals Treating Adenocarcinoma Risk calculators and risk factors for Adenocarcinoma
|
Healthcare Provider Resources |
Causes & Risk Factors for Adenocarcinoma |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Adenocarcinoma is a form of carcinoma that originates in glandular tissue. To be classified as adenocarcinoma, the cells do not necessarily need to be part of a gland, as long as they have secretory properties. This form of carcinoma can occur in some higher mammals, including humans.[1] The term adenocarcinoma is derived from 'adeno' meaning 'pertaining to a gland' and 'carcinoma', which describes a cancer that has developed in the epithelial cells. It can first present as an adenoma (a glandular tumor that is benign).
Pathophysiology
Examples of tissues where adenocarcinomas may arise:
- Breast cancer
- Colon cancer
- Lung cancer
- Prostate cancer
- Stomach cancer
- Pancreatic cancer (99% of pancreatic cancers are ductal adenocarcinomas [2])
- Cervical cancer
- Vaginal cancer
Gross Pathology
-
This cancer presented in a 40-year-old woman complaining of abdominal pain. Endoscopically it was a "very suspicious" ulcer. Biopsy showed diffusely infiltrating signet ring cell adenocarcinoma. These are gross photos of the subtotal gastrectomy specimen. The photo above is a seen face view of the ulcer. The pyloric margin is to the left. The ulcer is on the lesser curvature.
-
This is a longitudinal section cut in the plane of the lesser curvature. The pylorus is to the left. Note several prominent nodes of the lesser omentum; these contained metastatic cancer.
Physical Examination
Adenocarcinoma-In The Submandibular Salivary Glands
-
Adenocarcinoma-In The Submandibular Salivary Glands
Adapted from Dermatology Atlas -
Adenocarcinoma-In The Submandibular Salivary Glands
Adapted from Dermatology Atlas -
Adenocarcinoma-In The Submandibular Salivary Glands
Adapted from Dermatology Atlas
Differential Diagnosis
Diseases | Risk factors/Epidemiology | History | Clinical Findings | Gross Pathology | Histopathology | Immunohistochemistry | Lab Findings | Imaging | Metastatic Potential | Gold Standard | Additional Findings |
---|---|---|---|---|---|---|---|---|---|---|---|
Head & Neck Cancer | |||||||||||
Paranasal Sinus Cancer | |||||||||||
Lung Cancer | |||||||||||
Breast Cancer | |||||||||||
Esophageal Cancer | |||||||||||
Diseases | Risk factors/Epidemiology | History | Clinical Findings | Gross Pathology | Histopathology | Immunohistochemistry | Lab Findings | Imaging | Metastatic Potential | Gold Standard | Additional Findings |
Gastric Cancer | |||||||||||
Pancreatic Cancer | |||||||||||
Small Bowel Cancer | |||||||||||
Colorectal Cancer | |||||||||||
Appendix Cancer | |||||||||||
Diseases | Risk factors/Epidemiology | History | Clinical Findings | Gross Pathology | Histopathology | Immunohistochemistry | Lab Findings | Imaging | Metastatic Potential | Gold Standard | Additional Findings |
Gallbladder Cancer | |||||||||||
Anal Cancer | |||||||||||
Cervical Cancer | |||||||||||
Vaginal Cancer | |||||||||||
Endometrial Cancer | |||||||||||
Vulvar Cancer | |||||||||||
Diseases | Risk factors/Epidemiology | History | Clinical Findings | Gross Pathology | Histopathology | Immunohistochemistry | Lab Findings | Imaging | Metastatic Potential | Gold Standard | Additional Findings |
Prostate Cancer | |||||||||||
Testicular Cancer | |||||||||||
Urinary Bladder Cancer | |||||||||||
Urethral Cancer | |||||||||||
Metastatic Cancer | |||||||||||
Cancer of Unknown Primary |
References
- ↑ Fauquier, D.A., Gulland, F.M.D.,(Marine Mammal Center), Haulena, M., Spraker, T., ‘’Biliary adenocarcinoma in a stranded Northern elephant seal (‘’Mirounga angustirortsis’‘)’‘, Journal of Wildlife Diseases 39(3):723-726 (2003)